Atlas Oncology Partners
Delivers uplifting and responsive cancer care during and beyond treatment
$28MSeries A
Role not disclosedRF
Rubicon Founders
Activity from announced rounds
Activity in this selectionOct 24, 2026 · Biotech · Jan 1, 2026
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $28M 1 disclosed · full round size, not this investor’s share